Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.
P/B ratio for Titan Medical Inc. (TMDI)
P/B ratio as of 2023: 1.43
According to Titan Medical Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.43. At the end of 2022 the company had a P/B ratio of -23.40.
P/B ratio history for Titan Medical Inc. from 2007 to 2023
P/B ratio at the end of each year
| Year | P/B ratio |
|---|---|
| 2023 | 1.43 |
| 2022 | -23.40 |
| 2021 | 1.95 |
| 2020 | -8.26 |
| 2019 | -1.31 |
| 2018 | 4.89 |
| 2017 | 7.17 |
| 2016 | 58.62 |
| 2015 | -190.43 |
| 2014 | 3.82 |
| 2013 | 31.12 |
| 2012 | 16.67 |
| 2011 | 7.84 |
| 2010 | 6.63 |
| 2009 | 4.26 |
| 2008 | 3.26 |
| 2007 | 30.14 |